4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-030301
Director sold 2,000 shares at an average $34.75 ($69,496)
- Director acquired 2,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HERSHBERG ROBERT Director | 2020-05-15 | Option exercise | +2,000 | $0.45 | $900 | 2,000 | D |
| HERSHBERG ROBERT Director | 2020-05-15 | Sale | −1,202 | $34.14 | $41,036 | 798 | D |
| HERSHBERG ROBERT Director | 2020-05-15 | Sale | −400 | $35.23 | $14,092 | 398 | D |
| HERSHBERG ROBERT Director | 2020-05-15 | Sale | −398 | $36.10 | $14,368 | 0 | D |
| Derivatives | |||||||
| HERSHBERG ROBERT Director | 2020-05-15 | Option exercise · Stock Option (Right to Buy) | −2,000 | 73,000 | D | ||
| Open-market sales · 2,000 sh · avg $34.75 · $69,496 | |||||||
Loading xslF345X03/doc4.xml…